株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療用大麻の世界市場:成長、動向、予測(2019~2024年)

Medical Marijuana Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 802328
出版日 ページ情報 英文 118 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.77円で換算しております。
医療用大麻の世界市場:成長、動向、予測(2019~2024年) Medical Marijuana Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年02月01日 ページ情報: 英文 118 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

医療用大麻市場は、医療用大麻の使用を合法化する国の増加、大麻食用製品の生産動向、好ましい償還環境、政府の支援などにより成長しています。

当レポートでは、世界の医療用大麻市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場動向

  • 市場概要
  • 市場促進因子
    • 医療用大麻の使用を合法化する国の増加
    • 大麻食品製品の生産動向
    • 好ましい償還環境と政府の支援
  • 市場阻害因子
    • 服用に関する認識不測と大麻の薬用特性
    • 大麻の使用に関する社会的汚名
  • ポーターズファイブフォース分析

第5章 市場セグメンテーション

  • 用途別
    • 慢性疼痛
    • 関節炎
    • 片頭痛
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合環境

  • 企業プロファイル
    • Canopy Growth
    • Lexaria Corp.
    • United Cannabis Corporation
    • Aurora Cannabis
    • Cannabis Sativa Inc.
    • Cara Therapeutics Inc.
    • GW Pharmaceuticals PLC
    • LivWell Enlightened Health LLC
    • Aphria Inc
    • Medical Marijuana Inc.
    • Lexaria Corporation
    • United Cannabis Corporation
    • Aurora Cannabis
    • Cannabis Sativa Inc.

第7章 市場の機会と将来動向

目次
Product Code: 62304

Market Overview

The major factors for the growth of the medical marijuana market include the increasing number of countries legalizing the use of medical marijuana, trend of producing edible products with cannabis, and favorable reimbursement environment and government support in selected countries, which are expected to experience a boost over the forecast period.

Each year, the legal use of cannabis for medical and recreational purposes is steadily growing, but it varies across countries, based on the possession, distribution, cultivation, and medical indications for its consumption. Therefore, over the forecast period, the change is expected to be slow, but more legal consumption of cannabis is expected in the developed market, which is expected to largely drive the market studied.

Currently, there is also an increasing use of marijuana as a functional food, with purported health benefits far outnumbering what consumers can get from kale, turmeric, or kombucha. With the new generation growing up in the United States, where cannabis is legal, new products are found rapidly entering the market, which is expected to grow rapidly over the forecast period. The growth of the market is also attributed to factors, like the trends of producing edible products with cannabis in selected countries. Therefore marijuana is expected to be included in the 2018 food trends, as the drug and its ingredients have been gradually making their way into the public market.

Doctors also prescribe medical marijuana to treat muscle spasms caused by multiple sclerosis, nausea, poor appetite, and weight loss, caused by chronic illness, such as HIV, nerve pain, and Crohn's disease. Thus, with the increasing applications, there is a huge opportunity for marijuana for medicinal purposes as well.

Scope of the Report

As per the scope of the report, medical marijuana refers to the whole, unprocessed marijuana plant, or its basic extracts, for the treatment of several diseases and other related symptoms. Scientific studies show that chemical cannabinoids could help treat a range of diseases and symptoms, which has attracted several biopharmaceutical companies, globally, over the past two decades. The market is expected to witness significant growth, owing to legalization in several countries and high demand for both medical and recreational purposes.

Key Market Trends

Chronic Pain is the Segment under Application that is Expected to Experience the Fastest Growth during the Forecast Period

There are many studies that have shown that medical cannabis is found to be an effective method for the treatment of chronic pain, and that it is far safer than many other options. It is an affordable, natural alternative that lacks side effects and is traditionally used to treat chronic pain. There are also several ongoing researches on medical marijuana for the treatment of chronic pain, which is expected to directly impact the growth of the market.

Marijuana is also being used for the treatment of arthritis, as it has the potential to reduce inflammation, as well reduce pain. There is also an increasing research on medical marijuana for the treatment of cancer and commercially available cannabinoids, which are approved drugs for chemotherapy, and which are likely to augment the growth of the market. Marijuana, being an effective treatment for neuropathic pain, is expected to further rise over the forecast timeframe.

North America Accounted for the Largest Share in the Global Market

North America holds the major share in the medical marijuana market, and is expected to show a similar trend over the forecast period, without significant fluctuations. The surging pace of cannabis legalization in the United States is one of the key factors contributing to its increased demand. There are also many marijuana programs in the United States that have accelerated, and most of the states have started to approach medical marijuana from the perspective of good public health.

Competitive Landscape

The market studied is dominated by a few major players, and currently, only in a few countries, the use of cannabis is legal. Because of this, several companies were not able to launch their products.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Number of Countries Legalizing the Use of Medical Marijuana
    • 4.2.2 Trend of Producing Edible Products with Cannabis
    • 4.2.3 Favorable Reimbursement Environment and Government Support in Certain Countries
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness about the Dosage and Medicinal Properties of Marijuana
    • 4.3.2 Social Stigma Related to Cannabis Use
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Application
    • 5.1.1 Chronic Pain
    • 5.1.2 Arthritis
    • 5.1.3 Migraine
    • 5.1.4 Cancer
    • 5.1.5 Other Applications
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle East & Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle East & Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canopy Growth
    • 6.1.2 Lexaria Corp.
    • 6.1.3 United Cannabis Corporation
    • 6.1.4 Aurora Cannabis
    • 6.1.5 Cannabis Sativa Inc.
    • 6.1.6 Cara Therapeutics Inc.
    • 6.1.7 GW Pharmaceuticals PLC
    • 6.1.8 LivWell Enlightened Health LLC
    • 6.1.9 Aphria Inc
    • 6.1.10 Medical Marijuana Inc.
    • 6.1.11 Lexaria Corporation
    • 6.1.12 United Cannabis Corporation
    • 6.1.13 Aurora Cannabis
    • 6.1.14 Cannabis Sativa Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS